Literature DB >> 9455530

Failure of all antifungal therapy for infection due to Candida albicans: a new AIDS-related problem?

D Landman1, G Saurina, J M Quale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9455530     DOI： 10.1086/516287

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.

Authors:  Eduardo G Arathoon; Eduardo Gotuzzo; L Miguel Noriega; Rayanne S Berman; Mark J DiNubile; Carole A Sable
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.

Authors:  E J Helmerhorst; I M Reijnders; W van't Hof; I Simoons-Smit; E C Veerman; A V Amerongen
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.